Bank Of New York Mellon Corp Evolus, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$7.81 - $11.05 $964,909 - $1.37 Million
123,548 New
123,548 $1.05 Billion
Q4 2022

Feb 14, 2023
BUY
$6.52 - $8.95 $797,154 - $1.09 Million
122,263 New
122,263 $918,000
Q3 2022

Nov 14, 2022
SELL
$7.76 - $13.72 $304,564 - $538,482
-39,248 Reduced 24.3%
122,278 $983,000
Q2 2022

Aug 15, 2022
BUY
$10.22 - $13.94 $556,990 - $759,730
54,500 Added 50.92%
161,526 $1.87 Million
Q1 2022

May 11, 2022
BUY
$5.22 - $11.78 $7,683 - $17,340
1,472 Added 1.39%
107,026 $1.2 Million
Q4 2021

Feb 11, 2022
BUY
$5.37 - $8.38 $9,918 - $15,477
1,847 Added 1.78%
105,554 $688,000
Q3 2021

Nov 12, 2021
BUY
$7.36 - $13.67 $122,352 - $227,250
16,624 Added 19.09%
103,707 $791,000
Q2 2021

Aug 11, 2021
BUY
$8.42 - $13.96 $92,460 - $153,294
10,981 Added 14.43%
87,083 $1.1 Million
Q1 2021

May 13, 2021
SELL
$3.2 - $16.51 $1,340 - $6,917
-419 Reduced 0.55%
76,102 $988,000
Q4 2020

Feb 09, 2021
SELL
$2.92 - $4.84 $20,498 - $33,976
-7,020 Reduced 8.4%
76,521 $257,000
Q3 2020

Nov 12, 2020
SELL
$3.03 - $5.48 $3,284 - $5,940
-1,084 Reduced 1.28%
83,541 $326,000
Q2 2020

Aug 12, 2020
BUY
$3.53 - $6.17 $9,467 - $16,547
2,682 Added 3.27%
84,625 $448,000
Q1 2020

May 06, 2020
SELL
$3.53 - $12.21 $4,017 - $13,894
-1,138 Reduced 1.37%
81,943 $340,000
Q4 2019

Feb 14, 2020
BUY
$11.58 - $17.37 $385,729 - $578,594
33,310 Added 66.93%
83,081 $1.01 Million
Q3 2019

Nov 07, 2019
BUY
$13.91 - $19.87 $127,067 - $181,512
9,135 Added 22.48%
49,771 $777,000
Q2 2019

Aug 12, 2019
SELL
$13.19 - $28.36 $206,779 - $444,599
-15,677 Reduced 27.84%
40,636 $594,000
Q1 2019

May 14, 2019
BUY
$12.43 - $28.91 $327,791 - $762,385
26,371 Added 88.07%
56,313 $1.27 Million
Q4 2018

Feb 11, 2019
BUY
$10.57 - $19.29 $101,207 - $184,701
9,575 Added 47.01%
29,942 $356,000
Q3 2018

Nov 09, 2018
BUY
$17.31 - $29.82 $86,636 - $149,249
5,005 Added 32.58%
20,367 $0
Q2 2018

Aug 06, 2018
BUY
$6.85 - $38.49 $105,229 - $591,283
15,362 New
15,362 $430,000

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email